TLR3 and cancer: In addition, TLR3 acts directly as a death receptor [14] in cancer cells of various origins including breast [15], melanoma [16], mesothelioma [17], head and neck [18], prostate [19], renal carcinoma [20], colon [21], oral, and lung cancer cells [3].